相关实验视频

Updated: Jun 8, 2026

Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence

Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence

Published on: April 27, 2018

基于金门组装的非核糖体合成酶的高通量工程和修改

Adrian Podolski^1,2, Timon A Lindeboom³, Leonard Präve^1,2

¹Department of Natural Products in Organismic Interactions, Max Planck Institute for Terrestrial Microbiology, 35043, Marburg, Germany.

Angewandte Chemie (International ed. in English)

|October 11, 2025

概括

这项研究引入了一种新的方法,用于使用金门组合 (GGA) 和 eXchange Unit Thiolation域 (XUT) 概念的非核糖体合成酶 (NRPS) 工程. 这种方法使新型NRPS酶和定制的衍生物的高吞吐量生成为潜在的制药应用.

科学领域:

生物化学和分子生物学
合成生物学合成生物学
自然产品药物发现药物发现

背景情况:

非核糖体合成酶 (NRPS) 对于产生具有治疗潜力的复杂至关重要.
化学合成通常需要修改天然,这给可持续性带来了挑战.
在NRPS的体内工程为创建新结构提供了一个可持续的替代方案.

研究的目的:

使用 eXchange Unit Thiolation domain (XUT) 概念开发一个高通量方法来设计NRPS.
为了创建混合NRPS酶的多样化的库.
通过对现有NRPS系统的有针对性的修改来产生新型衍生物.

主要方法:

利用金门组件 (GGA) 进行NRPS碎片的高效模块化组装.
实现了用于NRPS工程的 eXchange Unit Thiolation域 (XUT) 概念.
应用该方法生成NRPS库并修改胺素生物合成基因集群 (BGC).

主要成果:

通过不同的启动,延伸和终止模块成功生成了100多个新的NRPS酶.
通过对 xabABCD BGC 的有针对性的修改,创造了 25 种新型的胺衍生物.
证明了基于GGA的XUT方法在NRPS工程中的效率和多功能性.

结论:

基于GGA的XUT方法为高通量NRPS工程提供了一个强大的工具.
这种方法促进了定制和新药候选物的合理设计和生产.
允许NRPS在体内进行可持续的修改,用于制药开发.

关键词:

工程工程师工程师工程师在此之前,NRPS是NRPS.非核糖体合成酶的非核糖体合成酶.这是一种类.合成生物学合成生物学

更多相关视频

Genetic Modification of Cyanobacteria by Conjugation Using the CyanoGate Modular Cloning Toolkit

Genetic Modification of Cyanobacteria by Conjugation Using the CyanoGate Modular Cloning Toolkit

Published on: October 31, 2019

Rapid Assembly of Multi-Gene Constructs using Modular Golden Gate Cloning

Rapid Assembly of Multi-Gene Constructs using Modular Golden Gate Cloning

Published on: February 5, 2021

相关概念视频

Bioreactor Controls-III

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

Production of Pharmaceuticals

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...